Clinical Trials
3 trialsNCT00472303 2019-11-04
A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Completed
NCT01946555 2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
NCT00805142 2013-07-29
Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants
Janssen Pharmaceutical K.K.
Phase 2 Completed